These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30728806)

  • 1. Upregulated Interleukin 21 Receptor Enhances Proliferation and Epithelial-Mesenchymal Transition Process in Benign Prostatic Hyperplasia.
    Xu D; Chen P; Xiao H; Wang X; DiSanto ME; Zhang X
    Front Endocrinol (Lausanne); 2019; 10():4. PubMed ID: 30728806
    [No Abstract]   [Full Text] [Related]  

  • 2. Upregulated bone morphogenetic protein 5 enhances proliferation and epithelial-mesenchymal transition process in benign prostatic hyperplasia via BMP/Smad signaling pathway.
    Liu D; Liu J; Li Y; Liu H; Hassan HM; He W; Li M; Zhou Y; Fu X; Zhan J; Wang Z; Yang S; Chen P; Xu D; Wang X; DiSanto ME; Zeng G; Zhang X
    Prostate; 2021 Dec; 81(16):1435-1449. PubMed ID: 34553788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. M2a macrophage can rescue proliferation and gene expression of benign prostate hyperplasia epithelial and stroma cells from insulin-like growth factor 1 knockdown.
    Qian Q; He W; Liu D; Yin J; Ye L; Chen P; Xu D; Liu J; Li Y; Zeng G; Li M; Wu Z; Zhang Y; Wang X; DiSanto ME; Zhang X
    Prostate; 2021 Jun; 81(9):530-542. PubMed ID: 33861464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simvastatin Improves Benign Prostatic Hyperplasia: Role of Peroxisome-Proliferator-Activated Receptor-γ and Classic WNT/β-Catenin Pathway.
    Wang Z; Yang S; Li Y; Zhou Y; Liu D; Liu J; DiSanto ME; Zhang X
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutathione Peroxidase 3 induced mitochondria-mediated apoptosis via AMPK /ERK1/2 pathway and resisted autophagy-related ferroptosis via AMPK/mTOR pathway in hyperplastic prostate.
    Li Y; Zhou Y; Liu D; Wang Z; Qiu J; Zhang J; Chen P; Zeng G; Guo Y; Wang X; DiSanto ME; Zhang X
    J Transl Med; 2023 Aug; 21(1):575. PubMed ID: 37633909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of Oxytocin Receptor in the Hyperplastic Prostate.
    Li Z; Xiao H; Wang K; Zheng Y; Chen P; Wang X; DiSanto ME; Zhang X
    Front Endocrinol (Lausanne); 2018; 9():403. PubMed ID: 30123183
    [No Abstract]   [Full Text] [Related]  

  • 7. Growth hormone-releasing hormone antagonists reduce prostatic enlargement and inflammation in carrageenan-induced chronic prostatitis.
    Popovics P; Cai R; Sha W; Rick FG; Schally AV
    Prostate; 2018 Sep; 78(13):970-980. PubMed ID: 29786867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of RhoA regulating benign prostatic hyperplasia: RhoA-ROCK-β-catenin signaling axis and static & dynamic dual roles.
    Shan S; Su M; Li Y; Wang Z; Liu D; Zhou Y; Fu X; Yang S; Zhang J; Qiu J; Liu H; Zeng G; Chen P; Wang X; DiSanto ME; Guo Y; Zhang X
    Mol Med; 2023 Oct; 29(1):139. PubMed ID: 37864185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting androgen receptor to suppress macrophage-induced EMT and benign prostatic hyperplasia (BPH) development.
    Lu T; Lin WJ; Izumi K; Wang X; Xu D; Fang LY; Li L; Jiang Q; Jin J; Chang C
    Mol Endocrinol; 2012 Oct; 26(10):1707-15. PubMed ID: 22915828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NELL2 modulates cell proliferation and apoptosis via ERK pathway in the development of benign prostatic hyperplasia.
    Liu J; Liu D; Zhang X; Li Y; Fu X; He W; Li M; Chen P; Zeng G; DiSanto ME; Wang X; Zhang X
    Clin Sci (Lond); 2021 Jul; 135(13):1591-1608. PubMed ID: 34195782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P. gingivalis in oral-prostate axis exacerbates benign prostatic hyperplasia via IL-6/IL-6R pathway.
    Wang SY; Cai Y; Hu X; Li F; Qian XH; Xia LY; Gao B; Wu L; Xie WZ; Gu JM; Deng T; Zhu C; Jia HC; Peng WQ; Huang J; Fang C; Zeng XT
    Mil Med Res; 2024 May; 11(1):30. PubMed ID: 38764065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STEAP4 modulates cell proliferation and oxidative stress in benign prostatic hyperplasia.
    Liu J; Zhou W; Yang L; Li Y; Qiu J; Fu X; Ren P; Guo F; Zhou Y; Liu J; Chen P; DiSanto ME; Zhang X
    Cell Signal; 2024 Jan; 113():110933. PubMed ID: 37866665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-18 may lead to benign prostatic hyperplasia via thrombospondin-1 production in prostatic smooth muscle cells.
    Hamakawa T; Sasaki S; Shibata Y; Imura M; Kubota Y; Kojima Y; Kohri K
    Prostate; 2014 May; 74(6):590-601. PubMed ID: 24615654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the expression and functional activities of Myosin II isoforms in human hyperplastic prostate.
    He W; Wang X; Zhan D; Li M; Wang Q; Liu J; Liu D; Fu X; Qian Q; Li Y; Chen P; Zeng G; Wang X; DiSanto ME; Zhang X
    Clin Sci (Lond); 2021 Jan; 135(1):167-183. PubMed ID: 33393635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose-regulated protein 78 modulates cell growth, epithelial-mesenchymal transition, and oxidative stress in the hyperplastic prostate.
    Fu X; Liu J; Liu D; Zhou Y; Guo Y; Wang Z; Yang S; He W; Chen P; Wang X; DiSanto ME; Zhang X
    Cell Death Dis; 2022 Jan; 13(1):78. PubMed ID: 35075122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estradiol promotes epithelial-to-mesenchymal transition in human benign prostatic epithelial cells.
    Shi X; Peng Y; Du X; Liu H; Klocker H; Lin Q; Shi J; Zhang J
    Prostate; 2017 Oct; 77(14):1424-1437. PubMed ID: 28850686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial-to-mesenchymal transition and estrogen receptor α mediated epithelial dedifferentiation mark the development of benign prostatic hyperplasia.
    Shao R; Shi J; Liu H; Shi X; Du X; Klocker H; Lee C; Zhu Y; Zhang J
    Prostate; 2014 Jun; 74(9):970-82. PubMed ID: 24752964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonists of growth hormone-releasing hormone inhibit proliferation induced by inflammation in prostatic epithelial cells.
    Popovics P; Schally AV; Salgueiro L; Kovacs K; Rick FG
    Proc Natl Acad Sci U S A; 2017 Feb; 114(6):1359-1364. PubMed ID: 28123062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the Expression and Functional Activities of C-X-C Motif Chemokine Ligand 13 (
    Liu D; Li M; Fu X; Yang S; Wang Z; Liu J; Li Y; Zhou Y; Ren P; Guo Y; Wang X; DiSanto ME; Chen P; Zhang X
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenic role of HIF-1α in prostate hyperplasia in the presence of chronic inflammation.
    Kim HJ; Park JW; Cho YS; Cho CH; Kim JS; Shin HW; Chung DH; Kim SJ; Chun YS
    Biochim Biophys Acta; 2013 Jan; 1832(1):183-94. PubMed ID: 22986049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.